Verastem, Inc. (VSTM)
5.60
-0.24
(-4.11%)
USD |
NASDAQ |
Mar 13, 16:00
5.60
0.00 (0.00%)
After-Hours: 20:00
Verastem Total Assets (Quarterly) : 246.44M for Dec. 31, 2025
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| Altimmune, Inc. | 279.93M |
| ADMA Biologics, Inc. | 633.35M |
| Ocugen, Inc. | 44.29M |
| Zevra Therapeutics, Inc. | 284.73M |
| Immuneering Corp. | 231.98M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 189.24M |
| Shareholders Equity (Quarterly) | 57.20M |
| Debt to Equity Ratio | 1.524 |
| Current Ratio | 3.092 |
| Net Debt Paydown Yield | -1.57% |